-
Vorinostat
- names:
Vorinostat
- CAS号:
149647-78-9
MDL Number: - MF(分子式): C14H20N2O3 MW(分子量): 264.32
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000608-500mg | 500mg | 99.9% | ¥ 1957.50 | ¥ 1957.50 | 2-3天 | ¥ 0.00 | ||
| YZM000608-250mg | 250mg | 99.9% | ¥ 1407.90 | ¥ 1407.90 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 149647-78-9 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C14H20N2O3 |
| 分子量 Molecular Weight | 264.32 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(378.33 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
Vorinostat(CAS:149647-78-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | Vorinostat 是一种有效的,可口服的HDAC1,HDAC2,HDAC3 (Class I),HDAC7 (Class II)和Class IV (HDAC11)的抑制剂,对 HDAC1/3 的ID50值分别为 10 nM 和 20 nM |
| Introduction | Vorinostat is a potent and orally available inhibitor of HDAC1,HDAC2andHDAC3 (Class I),HDAC7 (Class II)andHDAC11 (Class IV ), withID50values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. |
| Application1 | |
| Application2 | |
| Application3 |
Vorinostat 是一种有效的,可口服的HDAC1,HDAC2,HDAC3 (Class I),HDAC7 (Class II)和Class IV (HDAC11)的抑制剂,对 HDAC1/3 的ID50值分别为 10 nM 和 20 nM。Vorinostat is a potent and orally available inhibitor ofHDAC1,HDAC2andHDAC3 (Class I),HDAC7 (Class II)andHDAC11 (Class IV ), withID50values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively.
【1】.Hrzenjak A et al. Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo. Mol Cancer. 2010 Mar 4;9:49.
【2】.Lautz TB, et al. The effect of vorinostat on the development of resistance to Doxorubicin in neuroblastoma. PLoS One. 2012;7(7):e40816.
【3】.Richon VM, et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3003-7.
【4】.Xu WS, et al. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007 Aug 13;26(37):5541-52.
【5】.Pérez-Caamás A, et al. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease. Mol Psychiatry. 2017 May;22(5):711-723.
【6】.Wang J, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017 Dec 20;8(1):2207.
【2】.Lautz TB, et al. The effect of vorinostat on the development of resistance to Doxorubicin in neuroblastoma. PLoS One. 2012;7(7):e40816.
【3】.Richon VM, et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3003-7.
【4】.Xu WS, et al. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007 Aug 13;26(37):5541-52.
【5】.Pérez-Caamás A, et al. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease. Mol Psychiatry. 2017 May;22(5):711-723.
【6】.Wang J, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017 Dec 20;8(1):2207.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


